Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Downing

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
The New England Journal of Medicine|January 8, 1987
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialJ W Eschbach, J C Egrie, M R Downing, et al.
Contributions to Nephrology|January 1, 1991
The safety of epoetin-alpha: results of clinical trials in the United StatesJ W Eschbach, J C Egrie, M R Downing, et al.
Lancet (London, England)|November 22, 1986
Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysisC G Winearls, D O Oliver, M J Pippard, et al.
Molecular Biotherapy|January 1, 1989
Immunologic monitoring studies in advanced cancer patients treated with recombinant human gamma interferon (IFN-gamma 4A)P J Romano, A Lipton, H A Harvey, et al.
Journal of Biological Response Modifiers|June 1, 1988
A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancyR Perez, A Lipton, H A Harvey, et al.
Journal of Medical Virology|June 1, 1988
Hepatitis B vaccine produced in yeastG A Bitter, K M Egan, W N Burnette, et al.
Annals of Internal Medicine|December 15, 1989
Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trialJ W Eschbach, M H Abdulhadi, J K Browne, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
The New England Journal of Medicine|January 8, 1987
Correction of the anemia of end-stage renal disease with recombinant human erythropoietin. Results of a combined phase I and II clinical trialJ W Eschbach, J C Egrie, M R Downing, et al.
Contributions to Nephrology|January 1, 1991
The safety of epoetin-alpha: results of clinical trials in the United StatesJ W Eschbach, J C Egrie, M R Downing, et al.
Lancet (London, England)|November 22, 1986
Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysisC G Winearls, D O Oliver, M J Pippard, et al.
Molecular Biotherapy|January 1, 1989
Immunologic monitoring studies in advanced cancer patients treated with recombinant human gamma interferon (IFN-gamma 4A)P J Romano, A Lipton, H A Harvey, et al.
Journal of Biological Response Modifiers|June 1, 1988
A phase I trial of recombinant human gamma interferon (IFN-gamma 4A) in patients with advanced malignancyR Perez, A Lipton, H A Harvey, et al.
Journal of Medical Virology|June 1, 1988
Hepatitis B vaccine produced in yeastG A Bitter, K M Egan, W N Burnette, et al.
Annals of Internal Medicine|December 15, 1989
Recombinant human erythropoietin in anemic patients with end-stage renal disease. Results of a phase III multicenter clinical trialJ W Eschbach, M H Abdulhadi, J K Browne, et al.
Pageof 2